Top
Main
 
All Outcomes
 
Feedback
Home
c19early.org COVID-19 treatment researchSleepSleep (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

Loading...

Supplementary Data — Sleep for COVID-19: real-time meta analysis of 14 studies

@CovidAnalysis, November 2023
https://c19early.org/slmeta.html
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Cloosterman 32% 0.68 [0.43-1.07] symp. case 31/201 222/2,385 Improvement, RR [CI] Treatment Control Gao 36% 0.64 [0.42-0.97] cases case control Kim 17% 0.83 [0.70-0.99] m/s case 2,884 (all patients) Kim 11% 0.89 [0.81-0.97] cases 2,884 (all patients) COVIDENCE UK Holt 12% 0.88 [0.61-1.27] cases 15,227 (all patients) COVIDENCE UK Holt 12% 0.88 [0.68-1.14] cases 15,227 (all patients) COVIDENCE UK Holt 22% 0.78 [0.60-0.99] cases 15,227 (all patients) Marcus 16% 0.84 [0.76-0.93] symp. case 14,335 (all patients) Li 43% 0.57 [0.35-0.90] death 46,535 (all patients) Li 36% 0.64 [0.46-0.89] hosp. 46,535 (all patients) Li 21% 0.79 [0.64-0.96] hosp. 46,535 (all patients) Ahmadi 3% 0.97 [0.59-1.61] death 189/252,788 17/14,520 Mohsin 38% 0.62 [0.49-0.77] severe case 327/948 273/552 Huang 81% 0.19 [0.05-0.66] severe case 12/127 4/9 Paul 67% 0.33 [0.19-0.55] PASC 1,811 (all patients) LONG COVID Paul 54% 0.46 [0.28-0.74] PASC 1,811 (all patients) LONG COVID Jones 39% 0.61 [0.45-0.82] death n/a n/a Jones 32% 0.68 [0.56-0.82] hosp. n/a n/a Jones 7% 0.93 [0.86-1.00] cases n/a n/a Pływaczewska-J.. 17% 0.83 [0.68-1.01] m/s case 1,225 (n) 622 (n) Pływaczewska-J.. 7% 0.93 [0.73-1.16] PASC 1,015 (n) 502 (n) Wang 36% 0.64 [0.50-0.82] PASC 559 (n) 180 (n) LONG COVID Wang 18% 0.82 [0.69-0.99] PASC 1,979 (all patients) LONG COVID Wang 30% 0.70 [0.52-0.94] PASC 238 (n) 166 (n) LONG COVID Pavlidou 40% 0.60 [0.50-0.75] cases 3,345 (n) 1,852 (n) Sleep COVID-19 outcomes c19early.org November 2023 Favors good sleep Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of over 100,000 datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit